CareersPatient’s CornerDoctor’s Corner
News Center
Lahore Literary Festival 2017 – a breath of fresh air in the country 16 Mar 2017
Based on our commitment to encourage literature, creative expression and art in the country, Ferozsons Laboratories was amongst the proud supporters of Lahore Literary Fest 2017. The fifth edition of the annual LLF kicked off on Saturday, Feb. 25, at the Faletti’s Hotel. The free and open-to-public event featured prominent writers, historians, artists and key opinion leaders from home and abroad, who in a series of introspective and insightful discussions touched upon different facets of the socio-political changes unfolding in the world. In addition to crème de la crème of the country; the event was attended and enjoyed .... readmore
Art breathes life in clinical settings 02 Mar 2017
Ferozsons has been working closely with artists and the art community over the years to explore how it can play a positive role in clinical settings. Projects utilizing art for improved healthcare were carried out including the patient’s ward at Mayo Hospital in Lahore and patient’s waiting area at Jinnah Postgraduate Medical Center in Karachi. Both these projects make an effort to bring a pleasant change to the otherwise mundane environs of the hospitals. A new project with the help of Ziauddin University Hospital is now complete that has painted the kid’s play area in an exciting mélange of colours. Adeela Suleman, Head .... readmore
PepsiCo Pakistan collaborates with Ferozsons Laboratories for Hepatitis C awareness 02 Mar 2017
Ferozsons Laboratories Limited is making efforts to spread the message of awareness and prevention against Hepatitis C to multiple stakeholders in the society. A part of this effort is to reach out to private sector companies to further the cause of the elimination of Hepatitis C. PepsiCo Pakistan, taking a leadership role in this area, collaborated with Ferozsons Laboratories Limited to spread the message of awareness and prevention at their head office to educate the employees. The kickoff session carried information about the disease, followed by screening of Hepatitis C, as well as a presentation form a renowned hepat.... readmore
Community Projects Promise Elimination Of Hepatitis 28 Feb 2017
Ferozsons Laboratories Limited is committed to the cause of hepatitis elimination with experience spanning a decade in providing world class treatments in Hepatology provided to thousands of patients across Pakistan. A new project that works with and in the communities is leading to new partnerships that promise appropriate screening, prevention and treatment of Hepatitis C patients. The community based projects, a pilot of which is being run at two locations in Central Punjab with some of the leading NGO's and community clinics engaged in liver care, is not only screening patients but is also looking at educating communit.... readmore
Ferozsons partners with GE Healthcare 28 Dec 2016
Ferozsons partners with GE Healthcare Ferozsons Laboratories Limited has entered into a non-exclusive international distribution agreement with GE Healthcare FZE. The agreement is effective as of the 1st of June 2016 until 31st of May 2017, and is subject to annual review. Under the agreement, Ferozsons will promote and sell the following selected GE Healthcare products in Pakistan: • Non-exclusive rights for promotion and sale for the Value Segment of Ultrasound products which includes; LOGIQ V series; LOGIQ C series; LOGIQ F series; Vscan series; Voluson P6; Voluson P8; Vivid T8; View Point; Echo Pac and Im.... readmore
Ferozsons organizes Liver Summit 2016 05 Dec 2016
Ferozsons organized the sixth annual Liver Summit 2016 with support from Gilead Sciences, Inc. in partnership with International Association for the Study of the Liver (IASL). Established in 1958, IASL is the oldest professional association of clinicians and scientists dedicated to translating liver research into clinical practice through national, regional, and international educational activities. Gilead and Ferozsons to organize the sixth annual session for Pakistani clinicians who benefit from the latest the latest scientific and evidence-based research studies shared by leading international experts. In the last six.... readmore
Ferozsons committed to advancing heart health 29 Sep 2016
Ferozsons Laboratories Limited has a history of introducing breakthrough products for heart health over the years, and is proud of its heritage of serving one of the most prevalent non-communicable diseases (NCDs) in Pakistan through a portfolio of holistic solutions that include pharmaceuticals and medical devices. Historically, the company has introduced new molecules and generics as a result of international collaboration and local expertise in the field of medicine. From management of blood pressure to high cholesterol, and treatment of angina and heart failure, Ferozsons’ portfolio for heart health caters to the medic.... readmore
Ferozsons celebrates World Hepatitis Day 28 Jul 2016
Ferozsons Laboratories Limited is celebrating the World Hepatitis Day by holding a number of activities. As a market leader in Hepatology, the company is working on initiatives with healthcare professionals, general public and the community organizations to spread the message of hepatitis prevention, awareness and access to treatment. In some key initiatives, a Hepatitis C awareness pamphlet that will be circulated to doctors and patients, has been designed. A supplement marking World Hepatitis Day with special messages from Pakistan Society of Gastroenterology, Pakistan Society of Hepatology and Pakistan Society for the S.... readmore
Ferozsons amongst 27 companies as Pakistan secures Emerging Markets rating 16 Jun 2016
Morgan Stanley Capital International (MSCI) announced to include Pakistan in the Emerging Markets category from Frontier Markets. The formal inclusion will be done in 2017. Emerging Markets inclusion means reducing the number of listed companies from 36 to 27 in indices. Ferozsons Laboratories is featured in the 27 and is clubbed with the small market cap companies. In the last few years, Ferozsons witnessed an incredible trajectory of growth and is now amongst the top ten pharmaceutical companies in Pakistan. The status awarded to Pakistan by MSCI is a testament to the good performance of the stock exchanges in the recent.... readmore
Gilead and Ferozsons’ Hepatitis C Access Program appreciated 30 May 2016
A recent report published by leading business daily, the Business Recorder, appreciates the partnership between Ferozsons Laboratories Limited and Gilead Sciences Inc. to implement the Access Program for Hepatitis C Virus (HCV), offering the breakthrough treatment, Sovaldi in Pakistan at a fraction of its international cost. Under the second phase of this access program, Ferozsons will now be manufacturing the first locally produced authorized generic of the drug Sovaldi at a highly reduced cost to reach an even larger number of patients in Pakistan. The report suggests that access programs that bring innovative and breakt.... readmore
Saving hearts with latest technology of Rotablation 29 May 2016
Ferozsons Laboratories Limited, the authorized distributor for Boston Scientific Corp., a global leader in medical devices manufacturing, organized a workshop at the Hayatabad Medical Complex (HMC) in Peshawar. The Rotablator workshop was successfully conducted and is named after the technology that is making it possible to remove calcium from blocked arteries and to put stents in patients suffering from coronary artery disease. An expert Interventional Cardiologist trained in the UK led the local team of Cardiologists and carried out this specialized procedure. The session targeted at engaging with Interventional Cardiolo.... readmore
Ferozsons to manufacture first authorized generic 16 May 2016
Ferozsons Laboratories Limited has recently obtained the manufacturing license along with requisite production process technology from Gilead Sciences, Inc. to manufacture an authorized generic of the breakthrough Hepatitis C Virus (HCV) treatment in Pakistan. The generic treatment is priced at a fraction of the originator access price in Pakistan. With this approval, Ferozsons is furthering its mission to expand the cure to new patients suffering from this deadly disease. Availability of this authorized generic version of the HCV treatment at such a reduced price will further expand quality treatment access to HCV cure .... readmore
Ferozsons celebrates World Hypertension Day 2016 09 May 2016
Ferozsons recently celebrated the World Hypertension Day in partnership with our customers and by arranging several patient awareness and general information programs across Pakistan. Top cardiologists and hypertension specialists spoke on the importance of this day and the grave challenges the disease poses to a large population in Pakistan. High blood pressure as it is commonly called, is known to be a ‘silent killer’ and is a leading cause of morbidity around the world. Pakistan Hypertension League states that Hypertension is the number 1 chronic health problem in Pakistan with approximately 50% of all adults at risk of.... readmore
Using art to impact public health spaces 11 Apr 2016
Ferozsons supported to initiate the first project in Karachi at the Jinnah Post-Graduate Medical Centre (JPMC). The project titled, Innovations in Public Space is done in collaboration with the Patient’s Aid Foundation, working at the JPMC for the benefit of poor patients. Baithak is the name given to the revamped space which was an informal waiting area for patients. Artist Naima Chaudhry designed the space that provides shade from the sun, comfortable seating and access to water and other basic necessities. This is just one of the many initiatives that planned by the LBF under Innovations in Public Space. .... readmore
Ferozsons is fastest growing amongst all pharma cos 31 Mar 2016
Ferozsons has become the fastest growing pharmaceutical company in Pakistan amongst the top ten companies, revealed the first quarter 2016 report issued by healthcare information monitor, IMS Health. In the last two years, Ferozsons has witnessed unprecedented growth mainly due to the Hepatitis C Virus (HCV) franchise. Ferozsons is now ranked no. 6 amongst the top ten corporates and has secured third place amongst national companies. This is a great achievement and what better year to do this as the company is set to complete 60 years of operations in Pakistan. Ferozsons is planning to continue on this growth trajectory .... readmore